Tidepool has new clinical insights and research initiatives related to diabetes management and automated insulin delivery ...
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced new clinical results ...
Tidepool, the nonprofit leader advancing innovation in diabetes technology, today unveiled new clinical insights and research ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果